Found: 26
Select item for more details and to access through your institution.
The dawn of "immune-revolution" in children: early experiences with checkpoint inhibitors in childhood malignancies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Erratum to: Phase 1 study of darolutamide (ODM-201), a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Exposure-response analyses of trastuzumab emtansine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Malignant bone tumors (other than Ewing's): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A triplet combination with capecitabine/oxaliplatin/irinotecan (XELOXIRI) plus cetuximab as first-line therapy for patients with metastatic colorectal cancer: a dose escalation study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population pharmacokinetics of trastuzumab emtansine in previously treated patients with HER2-positive advanced gastric cancer (AGC).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The potential usefulness of the Response Index in positron emission tomography assessing the therapeutic effect of pre-operative chemotherapy for advanced colorectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluation of the effect of new formulation, food, or a proton pump inhibitor on the relative bioavailability of the smoothened inhibitor glasdegib (PF-04449913) in healthy volunteers.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification.
- Published in:
- 2017
- By:
- Publication type:
- journal article
PRIMUM NON NOCERE: now and again an echo of DPD with capecitabine.
- Published in:
- 2017
- By:
- Publication type:
- letter
The earlier, the better: the effects of different administration timepoints of sorafenib in suppressing the carcinogenesis of VEGF in rats.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study.
- Published in:
- 2017
- By:
- Publication type:
- journal article